<?xml version="1.0" encoding="UTF-8" ?> 
<root> 
<TEXT type="str">| Topix    
The price of Bristol-Myers Squibb Company shares have declined to $47.74, which is only 3.6% above the three-year low of $46.01. Bristol-Myers Squibb is an American pharmaceutical company that manufactures prescription pharmaceuticals in several therapeutic areas, including cancer, HIV/AIDS, cardiovascular disease and diabetes. 
 Related Biotechnology, Pharmaceutical and Healthcare News   
Original Article: Stocks Reach Their &apos;-Year Low Prices 
  NEXT ARTICLE  More From BioPortfolio on &quot;Stocks Reach Their &apos;-Year Low Prices&quot;</TEXT> 
<TOPICS type="list"> 
</TOPICS> 
<DOCID type="str">695196304603</DOCID> 
<DCT type="str">2017-01-29T06:52:49Z</DCT> 
<TITLE type="str">Stocks Reach Their &apos;Year Low Prices</TITLE> 
</root>